Skip to content

Samuel V. Alworth

Chief Executive Officer at AcuraStem.

Earliest Form D on file: Jun 2026

Filed Jun 22, 2026

AcuraStem

Antisense drugs for ALS and frontotemporal dementia

Biotech, Pasadena CA

Signed as Chief Executive Officer

$0

sold of $5M offered

Form D

LinkedIn

Network

At AcuraStem

4 people